Literature DB >> 11593422

Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.

B E Peace1, M J Hughes, S J Degen, S E Waltz.   

Abstract

The receptor tyrosine kinase Ron is a member of the receptor family that includes the proto-oncogene Met and the avian oncogene Sea. The interaction of Ron with its ligand, known as hepatocyte growth factor-like protein (HGFL) or macrophage stimulating protein (MSP), induces crucial cellular responses including invasive growth, proliferation, cell scattering, and branching morphogenesis. Based on the homology and functional similarities between Met and Ron it was hypothesized that Ron may be important in tumor formation and metastasis. To test this hypothesis, wild-type mouse Ron and three mutant forms of Ron containing mutations similar to those found in the Met gene in human hereditary papillary renal carcinoma (HPRC), were expressed in NIH3T3 cells. A transformed phenotype was produced in cell lines expressing either wild-type Ron or the mutated Ron proteins. Further, these cell lines displayed oncogenic potential by exhibiting increased proliferation and constitutive phosphorylation of Ron. These cell lines were also tested for the ability to form solid tumors. Cells expressing wild-type Ron and the three proteins with single amino acid substitutions were highly tumorigenic in vivo. In a model of experimental metastasis, two of the cell lines with altered Ron protein formed highly aggressive tumors in the lungs. These results suggest that Ron may be an aggressive oncogene when either overexpressed or when activated by mutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593422     DOI: 10.1038/sj.onc.1204836

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  MET is a predictive factor for late recurrence but not for overall survival of early stage hepatocellular carcinoma.

Authors:  Young Wha Koh; Yang-Soon Park; Hyo Jeong Kang; Ju Hyun Shim; Eunsil Yu
Journal:  Tumour Biol       Date:  2015-02-10

2.  Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.

Authors:  Marceline Côté; A Dusty Miller; Shan-Lu Liu
Journal:  Biochem Biophys Res Commun       Date:  2007-06-18       Impact factor: 3.575

3.  Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.

Authors:  Purnima K Wagh; Glendon M Zinser; Jerilyn K Gray; Archana Shrestha; Susan E Waltz
Journal:  Endocrinology       Date:  2012-04-02       Impact factor: 4.736

Review 4.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

5.  The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.

Authors:  Ryan M Thomas; Dawn V Jaquish; Randall P French; Andrew M Lowy
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

6.  Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.

Authors:  Rebecca J McClaine; Aaron M Marshall; Purnima K Wagh; Susan E Waltz
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

7.  Activation of the N-terminally truncated form of the Stk receptor tyrosine kinase Sf-Stk by Friend virus-encoded gp55 is mediated by cysteine residues in the ecotropic domain of gp55 and the extracellular domain of Sf-Stk.

Authors:  Shihan He; Shuang Ni; Shailaja Hegde; Xin Wang; Daniel R Sharda; Avery August; Robert F Paulson; Pamela A Hankey
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

Authors:  Alana L Welm; Julie B Sneddon; Carmen Taylor; Dimitry S A Nuyten; Marc J van de Vijver; Bruce H Hasegawa; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

Review 9.  Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

Authors:  Purnima K Wagh; Belinda E Peace; Susan E Waltz
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

10.  The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells.

Authors:  M N Thobe; D Gurusamy; P Pathrose; S E Waltz
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.